Ask sales for the lot-numbered COA matched to the offered or supplied batch; it records the tests actually completed, their specifications, and the reported results.
Review the matching batch COA for the analytical scope and results recorded for that lot.
Matching batch COA available.
PCAC will review 7 peptides for the 503A bulks list, BPC-157, KPV, TB-500, MOTS-c, Emideltide, Semax, Epitalon. Read our briefing →
PCAC will review 7 peptides for the 503A bulks list. Read →
FDA PCAC reviews 7 peptides in July. Read →
Semax, Selank, DSIP, and related neuropeptides for cognitive, mood, and sleep research applications.
7-mer
ACTH 4-10 analog · cognitive research peptide
7-mer
Tuftsin analog · anxiolytic research peptide
9-mer
Delta sleep-inducing peptide
3-mer
Khavinson neuroprotective tripeptide (Glu-Asp-Arg, EDR)
35-mer
CNTF-derived neurogenic tetrapeptide with adamantane moiety
28-residue vasoactive / immune neuropeptide
25-mer
μ-opioid heptapeptide (D-Ala²) · analgesia research reference
19-mer
Angiotensin-IV-derived synaptogenic compound · cognition research
21-mer
Spadin-derived TREK-1 blocker heptapeptide · mood research
Applications & buyer fit
Cognitive and neuropeptide buyers are predominantly research labs running in vivo rodent studies. The dominant administration route in the literature is intranasal, these peptides are not meaningfully blood-brain-barrier permeable when delivered systemically. For in vivo workflows, endotoxin and microbial-limit testing is recommended at the COA stage so the bioassay readout is not confounded by contamination unrelated to the test article.
Buyer types across this category
Documentation available for this class
Sold for research use under the receiving laboratory's local regulations. Not a finished dosage form and not labeled for human administration. If an in vivo protocol requires endotoxin or microbial-limit data, include those items in the agreed analytical scope before quotation.